1 / 3

Global Xerostomia (Dry Mouth) Therapeutics Market

Theu00a0global xerostomia (dry mouth) therapeutics marketu00a0is projected to exhibit considerable growth during the forecast period. The high prevalence of this problem, a rapid rise in the R&D activities related to the development of different drugs and treatment options by the major market players is a major factor anticipated to fuel the market during the forecast period.

nabeelomr
Télécharger la présentation

Global Xerostomia (Dry Mouth) Therapeutics Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. The global xerostomia (dry mouth) therapeutics market is projected to exhibit considerable growth during the forecast period. The high prevalence of this problem, a rapid rise in the R&D activities related to the development of different drugs and treatment options by the major market players is a major factor anticipated to fuel the market during the forecast period. GlaxoSmithKline Plc, Church & Dwight Co., Inc., Colgate-Palmolive Co., Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc., Pfizer, Inc., Parnell Pharmaceuticals, Inc., Acacia Pharma Group Plc, Quest Products, LLC (OraCoat), EUSA Pharma NP, and so on are the key market players operating in the global xerostomia therapeutics market. (Get 15% Discount on Buying this Report) Get Report Sample Copy @https://www.omrglobal.com/request-sample/xerostomia-dry- mouth-therapeutics-market These market players are making hefty investments in their R&D sector to introduce new products and to perform innovation in their existing product offerings. For instance, in February 2020, Sunstar Americas Inc. had launched a wide range of Gum Hydral dry mouth relief products for the treatment of xerostomia or dry mouth. Gum Hydral is a kind of artificial saliva that provides advanced moisturizing and hydrating ingredients that perform their work like natural saliva to provide multisymptom relief in the dry mouth condition. A Full Report of Global IoT Sensors Market is Available at: https://www.omrglobal.com/industry-reports/xerostomia-dry-mouth-therapeutics-market In November 2018, 3M Company had launched a new Xerostomia Relief Spray. 3M Xerostomia Relief Spray is a lipid-based spray that offers relief in the dry mouth by moisturizing and lubricating the mucosa. This spray can be used only after taking a prescription from a healthcare professional. The xerostomia relief spray is conveniently portable and ready to use without any premixing or preparation requirements by the affected person. In October 2018, Synedgen had launched Moisyn Rinse for the treatment of the symptoms of xerostomia. Moisyn Rinse based on glycomic target-based therapy is being distributed by Prisyna, the oral care division of Synedgen. This rinse offers relief from the symptoms of dry mouth by moisturizing and lubricating of the oral cavity. Thus, the increasing product launches for the treatment of xerostomia are anticipated to be a major factor to drive the growth of the global xerostomia therapeutics market. Current Market Trends Covered in the Market Report The rapid increase in the R&D activities and product development related to xerostomia therapeutics. North America is anticipated to hold a major market share during the forecast period. The rising awareness among people related to the treatment of the disease to create an opportunity for market growth.

  2. New product launches– key drivers of competition in the xerostomia therapeutics market. Global Xerostomia (Dry Mouth) Therapeutics Market Segmentation By Product Type Artificial Saliva Dentifrices Salivary Stimulants Saliva Substitutes Drugs Salivary Pen By Type Prescription OTC Global Xerostomia (Dry Mouth) Therapeutics Market Segmentation by region North America United States Canada Europe Germany UK France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World

  3. Company Profiles 3M Co. Acacia Pharma Group Plc Bausch Health Companies, Inc. Colgate-Palmolive Co. Eisai, Inc. EUSA Pharma NP Forward Science GlaxoSmithKline Plc Reasons to Buying From us – 1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report. For https://www.omrglobal.com/report-customization/xerostomia-dry-mouth-therapeutics- market More Customized Data, Request for Report Customization @ About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404

More Related